Works matching IS 2160763X AND DT 2023 AND VI 12 AND IP 8

Results: 11

Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Novel Dual Delayed‐Release Formulation of Esomeprazole in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 839, doi. 10.1002/cpdd.1237

By:

Hwang, Sejung;
Hong, Sung Hee;
Jung, Jina;
Chung, Jae‐Yong;
Jang, In‐Jin;
Lee, SeungHwan

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 767, doi. 10.1002/cpdd.980
Publication type:: Article

Commentary on Improving the Efficiency of Clinical Pharmacology Studies.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 775, doi. 10.1002/cpdd.1295

By:

Fossler, Michael J.

Publication type:

Article

Improving the Efficiency of Clinical Pharmacology Studies.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 771, doi. 10.1002/cpdd.1274

By:

Polasek, Thomas M.;
Schuck, Virna

Publication type:

Article

Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Iberdomide.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 819, doi. 10.1002/cpdd.1254

By:

Cheng, Yiming;
Gaudy, Allison;
Liu, Liangang;
Ye, Ying;
Thomas, Michael;
Xue, Yongjun;
Zhou, Simon;
Li, Yan

Publication type:

Article

A Phase 1, Open‐Label, Fixed‐Sequence, Drug–Drug Interaction Study of Zanubrutinib with Rifabutin in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 832, doi. 10.1002/cpdd.1250

By:

Tariq, Bilal;
Conto, Stephanie;
Cohen, Aileen;
Sahasranaman, Srikumar;
Ou, Ying C.

Publication type:

Article

Rimegepant 75 mg in Subjects With Hepatic Impairment: Results of a Phase 1, Open‐Label, Single‐Dose, Parallel‐Group Study.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 790, doi. 10.1002/cpdd.1244

By:

Bhardwaj, Rajinder;
Ivans, Andrea;
Stringfellow, Joseph;
Morris, Beth;
Coric, Vladimir;
Croop, Robert;
Bertz, Richard

Publication type:

Article

Safety, Pharmacokinetics, and Antifibrotic Activity of CC‐90001 (BMS‐986360), a c‐Jun N‐Terminal Kinase Inhibitor, in Pulmonary Fibrosis.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 779, doi. 10.1002/cpdd.1294

By:

Horan, Gerald;
Ye, Ying;
Adams, Mary;
Parton, Anastasia;
Cedzik, Dorota;
Tang, Shaojun;
Brown, Elizabeth A.;
Liu, Liangang;
Nissel, Jim;
Carayannopoulos, Leonidas N.;
Gaudy, Allison;
Schafer, Peter;
Palmisano, Maria;
Ramirez‐Valle, Francisco

Publication type:

Article

Single‐ and Multiple‐dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1128, a Novel Peroxisome Proliferator‐activated Receptor δ Modulator, in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 810, doi. 10.1002/cpdd.1236

By:

Taniuchi, Yuta;
van Till, J. W. Olivier;
Wojtkowski, Tomasz;
Toyoshima, Junko;
Koibuchi, Akira;
Sargent, Briana;
Han, David

Publication type:

Article

Clinical Impact of Antipolyethylene Glycol (PEG) Antibody in Hematological Patients Administered PEGylated‐Granulocyte Colony‐Stimulating Factor.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 826, doi. 10.1002/cpdd.1225

By:

Okada, Naoto;
Taro, Shimizu;
Ando, Hidenori;
Nakamura, Shingen;
Goda, Mitsuhiro;
Abe, Masahiro;
Kitahara, Takashi;
Ishida, Tatsuhiro;
Ishizawa, Keisuke

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A<sub>2A</sub> Antagonist/Inverse Agonist KW‐6356 Following Single and Multiple Oral Administration in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 801, doi. 10.1002/cpdd.1222

By:

Tayama, Tomonori;
Ishiuchi, Masatake;
Sugiyama, Kenichiro;
Oka, Yuichi;
Maeda, Hiroshi;
Nagata, Yoshinori;
Hruska, Matthew;
Kagawa, Yoshiyuki

Publication type:

Article